These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12047397)

  • 1. Effects of gemfibrozil on insulin resistance to fat metabolism in subjects with type 2 diabetes and hypertriglyceridaemia.
    Whitelaw DC; Smith JM; Nattrass M
    Diabetes Obes Metab; 2002 May; 4(3):187-94. PubMed ID: 12047397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of gemfibrozil on lipid profile and glucose metabolism in hypertriglyceridaemic well-controlled non-insulin-dependent diabetic patients. For the Gemfibrozil Study Group.
    Avogaro A; Piliego T; Catapano A; Miola M; Tiengo A
    Acta Diabetol; 1999 Jun; 36(1-2):27-33. PubMed ID: 10436249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemfibrozil treatment of endogenous hypertriglyceridemia: effect on insulin-mediated glucose disposal and plasma insulin concentrations.
    Jeng CY; Sheu WH; Fuh MM; Shieh SM; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2550-3. PubMed ID: 8675576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia.
    Sane T; Knudsen P; Vuorinen-Markkola H; Yki-Järvinen H; Taskinen MR
    Metabolism; 1995 May; 44(5):589-96. PubMed ID: 7752906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lowering of triglycerides by gemfibrozil affects neither the glucoregulatory nor antilipolytic effect of insulin in type 2 (non-insulin-dependent) diabetic patients.
    Vuorinen-Markkola H; Yki-Järvinen H; Taskinen MR
    Diabetologia; 1993 Feb; 36(2):161-9. PubMed ID: 8458531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemfibrozil treatment of hypertriglyceridemia: improvement on fibrinolysis without change of insulin resistance.
    Jeng JR; Jeng CY; Sheu WH; Lee MM; Huang SH; Shieh SM
    Am Heart J; 1997 Sep; 134(3):565-71. PubMed ID: 9327717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients.
    Mussoni L; Mannucci L; Sirtori C; Pazzucconi F; Bonfardeci G; Cimminiello C; Notarbartolo A; Scafidi V; Bittolo Bon G; Alessandrini P; Nenci G; Parise P; Colombo L; Piliego T; Tremoli E
    Atherosclerosis; 2000 Feb; 148(2):397-406. PubMed ID: 10657576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gemfibrozil on the regulation of HDL subfractions in hypertriglyceridaemic patients.
    Kahri J; Sane T; van Tol A; Taskinen MR
    J Intern Med; 1995 Nov; 238(5):429-36. PubMed ID: 7595182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gemfibrozil therapy on glucose tolerance, insulin sensitivity and plasma plasminogen activator inhibitor activity in hypertriglyceridaemia.
    Asplund-Carlson A
    J Cardiovasc Risk; 1996 Aug; 3(4):385-90. PubMed ID: 8946270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).
    Robins SJ; Rubins HB; Faas FH; Schaefer EJ; Elam MB; Anderson JW; Collins D;
    Diabetes Care; 2003 May; 26(5):1513-7. PubMed ID: 12716814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients.
    Avogaro A; Miola M; Favaro A; Gottardo L; Pacini G; Manzato E; Zambon S; Sacerdoti D; de Kreutzenberg S; Piliego T; Tiengo A; Del Prato S
    Eur J Clin Invest; 2001 Jul; 31(7):603-9. PubMed ID: 11454015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double blind study of the effect of acipimox on serum lipids, blood glucose control and insulin action in non-obese patients with type 2 diabetes mellitus.
    Fulcher GR; Catalano C; Walker M; Farrer M; Thow J; Whately-Smith CR; Alberti KG
    Diabet Med; 1992 Dec; 9(10):908-14. PubMed ID: 1478035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin-dependent diabetes mellitus. NIDDM Study Group.
    Sweany AE; Shapiro DR; Tate AC; Goldberg RB; Stein EA
    Clin Ther; 1995; 17(2):186-203. PubMed ID: 7614520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia.
    Miller J; Brown D; Amin J; Kent-Hughes J; Law M; Kaldor J; Cooper DA; Carr A
    AIDS; 2002 Nov; 16(16):2195-200. PubMed ID: 12409741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemfibrozil treatment of the high triglyceride-low high-density lipoprotein cholesterol trait in men with established atherosclerosis.
    Knipscheer HC; Nurmohamed MT; Van den Ende A; Plaat B; Pruijs HJ; Mulder WJ; Kastelein JJ
    J Intern Med; 1994 Oct; 236(4):377-84. PubMed ID: 7931040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin action and glucose metabolism are improved by gemfibrozil treatment in hypertriglyceridemic patients.
    Avogaro A; Beltramello P; Marin R; Zambon S; Bonanome A; Biffanti S; Confortin L; Manzato E; Crepaldi G; Tiengo A
    Atherosclerosis; 1995 Feb; 113(1):117-24. PubMed ID: 7755647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altering triglyceride concentrations changes insulin-glucose relationships in hypertriglyceridemic patients. Double-blind study with gemfibrozil with implications for atherosclerosis.
    Steiner G
    Diabetes Care; 1991 Nov; 14(11):1077-81. PubMed ID: 1797490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
    Fruchart JC; Duriez P
    Drugs Today (Barc); 2006 Jan; 42(1):39-64. PubMed ID: 16511610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus.
    Schweitzer M; Tessier D; Vlahos WD; Leiter L; Collet JP; McQueen MJ; Harvey L; Alaupovic P
    Atherosclerosis; 2002 May; 162(1):201-10. PubMed ID: 11947915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.